日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical outcomes of older patients with NPM1-mutated or KMT2A-rearranged AML before menin inhibitors: a Beat AML report

在接受menin抑制剂治疗前,NPM1突变或KMT2A重排的AML老年患者的临床结局:Beat AML报告

Zeidner, Joshua F; Jain, Jayanshu; Welkie, Rina Li; Huang, Ying; Swords, Ronan T; Traer, Elie; Stein, Eytan M; Lin, Tara L; Madanat, Yazan F; Collins, Robert H; Baer, Maria R; Duong, Vu H; Blum, William G; Arellano, Martha L; Stock, Wendy; Odenike, Olatoyosi; Olin, Rebecca L; Smith, Catherine C; Foran, James M; Schiller, Gary J; Curran, Emily K; Handa, Shivani; Heerema, Nyla A; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G; Rosenberg, Leonard; Druker, Brian J; Levine, Ross L; Burd, Amy; Yocum, Ashley O; Mims, Alice S; Byrd, John C; Borate, Uma

American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults

美国血液学会 2025 年老年新诊断急性髓系白血病治疗指南

Sekeres, Mikkael A; Mattison, Ryan; Artz, Andrew; Baer, Maria R; Chua, Chong Chyn; Demichelis-Gómez, Roberta; Egan, Pamela C; Fletcher, Luke; Foucar, Charles; Garcia, Jacqueline S; Gilberto, Linda; Gómez de León, Andres; Lancet, Jeffrey; Loh, Kah Poh; Malcovati, Luca; Marini, Bernard; Platzbecker, Uwe; Sorror, Mohamed L; Tinsley-Vance, Sara; Treitz, John; Oliveros, Maria Jose; Ibrahim, Sara; Roldan, Yetiani; Guyatt, Gordon; Brignardello-Petersen, Romina

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML

阿扎胞苷、维奈托克和瑞伐美尼用于新诊断的NPM1突变或KMT2A重排急性髓系白血病

Zeidner, Joshua F; Lin, Tara L; Welkie, Rina Li; Curran, Emily; Koenig, Kristin; Stock, Wendy; Madanat, Yazan F; Swords, Ronan; Baer, Maria R; Blum, William; Stein, Eytan M; Olin, Rebecca L; Schiller, Gary; Nichols, Angela; Odenike, Olatoyosi; Traer, Elie; Lachowiez, Curtis; Duong, Vu H; Hochman, Michael J; Cai, Sheng F; Smith, Catherine; Stefanos, Mona; Martycz, Molly; Huang, Ying; Rosenberg, Len; Marcus, Sonja; Chen, Timothy L; Yocum, Ashley O; Druker, Brian J; Levine, Ross L; Borate, Uma; Byrd, John C; Mims, Alice S

Ziftomenib in Relapsed or Refractory NPM1-Mutated AML

Ziftomenib治疗复发或难治性NPM1突变型急性髓系白血病

Wang, Eunice S; Montesinos, Pau; Foran, James; Erba, Harry; Rodríguez-Arbolí, Eduardo; Fedorov, Kateryna; Heiblig, Maël; Heidel, Florian H; Altman, Jessica K; Baer, Maria R; Ades, Lionel; Pettit, Kristen; Peterlin, Pierre; Papayannidis, Cristina; Berthon, Céline; Walter, Roland B; Shah, Mithun V; Balasubramanian, Suresh; Khawandanah, Mohamad; Salamero Garcia, Olga; Bergeron, Julie; Madanat, Yazan F; Roboz, Gail J; Ulrickson, Matthew; Redner, Robert L; McCloskey, James; Pigneux, Arnaud; de la Fuente Burguera, Adolfo; Mitra, Amitava; Soifer, Harris S; Tabachri, Marilyn; Zhang, Zijing; Riches, Marcie; Corum, Daniel; Leoni, Mollie; Issa, Ghayas C; Fathi, Amir T

Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial

奥鲁西地尼联合阿扎胞苷可使复发或难治性mIDH1急性髓系白血病患者获得持久的完全缓解:一项多队列开放标签1/2期试验

Cortes, Jorge E; Roboz, Gail J; Baer, Maria R; Jonas, Brian A; Schiller, Gary J; Yee, Karen; Ferrell, P Brent; Yang, Jay; Wang, Eunice S; Blum, William G; Mims, Alice; Tian, Hua; Sheppard, Aaron; de Botton, Stéphane; Montesinos, Pau; Curti, Antonio; Watts, Justin M

Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia

影响健康的社会因素以及获得异基因造血干细胞移植治疗急性髓系白血病的机会

Wuliji, Natalie; Jones, Salene M W; Gooley, Ted; Gerds, Aaron T; Medeiros, Bruno C; Shami, Paul J; Galvin, John; Adekola, Kehinde; Luger, Selina; Baer, Maria R; Rizzieri, David; Wildes, Tanya M; Wang, Eunice S; Sekeres, Mikkael A; Mukherjee, Sudipto; Smith, Julie; Garrison, Mitchell; Kojouri, Kiarash; Appelbaum, Jacob; Percival, Mary-Elizabeth; Sandmaier, Brenda M; Lee, Stephanie; Appelbaum, Frederick R; Rouce, Rayne; Sorror, Mohamed L

Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes

维奈托克联合阿扎胞苷治疗初治高危骨髓增生异常综合征患者的疗效和安全性

Garcia, Jacqueline S; Platzbecker, Uwe; Odenike, Olatoyosi; Fleming, Shaun; Fong, Chun Yew; Borate, Uma; Jacoby, Meagan A; Nowak, Daniel; Baer, Maria R; Peterlin, Pierre; Chyla, Brenda; Wang, Huipei; Ku, Grace; Hoffman, David; Potluri, Jalaja; Garcia-Manero, Guillermo

A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemia

一项针对复发或难治性急性髓系白血病的氨基酸调节剂pegcrisantaspase和venetoclax的I期研究

Liu, Yuchen; Bollino, Dominique R; Bah, Osman M; Strovel, Erin T; Le, Tien V; Zarrabi, Jinoos; Philip, Sunita; Lapidus, Rena G; Baer, Maria R; Niyongere, Sandrine; Duong, Vu H; Dougherty, Christine C; Beumer, Jan H; Caprinolo, Katherine D; Kamangar, Farin; Emadi, Ashkan

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial

奥维瑞巴替尼用于酪氨酸激酶抑制剂(包括帕纳替尼或阿西米尼)治疗失败后的疗效:一项 1b 期随机临床试验

Jabbour, Elias; Oehler, Vivian G; Koller, Paul B; Jamy, Omer; Lomaia, Elza; Hunter, Anthony M; Uspenskaya, Olga; Samarina, Svetlana; Mukherjee, Sudipto; Cortes, Jorge E; Baer, Maria R; Zherebtsova, Vera; Shuvaev, Vasily; Turkina, Anna; Davydkin, Igor; Guo, Huanshan; Chen, Zi; Fu, Tommy; Jiang, Lixin; Wang, Cunlin; Wang, Hengbang; Yang, Dajun; Zhai, Yifan; Kantarjian, Hagop

Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3

ZUMA-3 研究对接受 brexucabtagene autoleucel 治疗的复发或难治性 B 细胞急性淋巴细胞白血病成年患者进行了为期三年的分析

Shah, Bijal D; Cassaday, Ryan D; Park, Jae H; Houot, Roch; Logan, Aaron C; Boissel, Nicolas; Leguay, Thibaut; Bishop, Michael R; Topp, Max S; O'Dwyer, Kristen M; Tzachanis, Dimitrios; Arellano, Martha L; Lin, Yi; Baer, Maria R; Schiller, Gary J; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C; Wierda, William G; DeAngelo, Daniel J; Stiff, Patrick; Jeyakumar, Deepa; Mao, Daqin; Adhikary, Sabina; Zhou, Lang; Hadjivassileva, Tsveta; Damico Khalid, Rita; Ghobadi, Armin; Oluwole, Olalekan O